
Glucosamine Linked to 25% Higher Dementia Progression Risk in Cognitive Impairment Patients
A University of Florida study published in Nature Metabolism finds that glucosamine use is associated with a 25% higher risk of progression from mild cognitive impairment to dementia. The research suggests the supplement may disrupt glycosylation, a process where sugar chains attach to proteins, potentially interfering with nerve cell communication in brains already affected by Alzheimer's-like changes. While observational data cannot prove causality, the findings highlight a potential safety signal for individuals with existing cognitive issues.













